Free Trial

Novavax (NVAX) SEC Filings & 10K Form

Novavax logo
$8.06 +0.06 (+0.75%)
(As of 11/20/2024 ET)

Recent Novavax SEC Filings

DateFilerForm TypeView
11/13/2024
3:05 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:08 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:21 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:01 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:19 PM
Novavax (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:08 PM
Dubovsky Filip (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:47 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:06 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:04 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:37 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
5:16 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/20/2024
4:08 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:35 PM
Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
Form SC 13G/A
06/06/2024
6:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
8:35 PM
Novavax (Filer)
Form DEFA14A
05/20/2024
1:42 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/20/2024
5:09 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/15/2024
8:15 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
1:39 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:05 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:53 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
4:21 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
1:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/06/2024
3:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/06/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form PREC14A
04/29/2024
6:58 AM
Novavax (Filer)
Form DEFA14A
04/29/2024
7:01 AM
Novavax (Filer)
Form ARS
04/29/2024
6:54 AM
Novavax (Filer)
Form DEF 14A
04/15/2024
11:18 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
04/15/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D
03/26/2024
6:00 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:00 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:01 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:02 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:03 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
5:11 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:45 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
03/11/2024
8:39 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:30 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:30 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
5:02 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
12:59 PM
MORGAN STANLEY (Filed by)
Novavax (Subject)
Form SC 13G
01/31/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
7:57 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
8:25 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
4:12 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
7:45 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVAX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners